Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,206.00    32.00 (1.47%)
Bid:
2,186.00
Ask:
2,200.00
Spread: 14.00 (0.64%)
Market Cap: £1.47b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

12 Sep 2019 14:59

RNS Number : 1736M
Genus PLC
12 September 2019
 

12 September 2019

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 11 September 2019, conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to an Executive Director and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2019, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2019 Annual Report.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 11 September 2019.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2014 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Dr Elena Rice

6. Angelle Rosata

7. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Chief Scientific Officer & Head of R&D

6. Group Human Resources Director

7. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the Genus plc 2014 Performance Share Plan over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 2,832p

41,666

2. 2,832p

17,682

3. 2,832p

14,892

4. 2,832p

14,806

5. 2,832p

15,450

6. 2,832p

14,163

7. 2,832p

14,512

d.

Aggregated information

·; Aggregated volume

·; Price

 

 

 

n/a

 

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Angelle Rosata

6. Dan Hartley

 

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Group Human Resources Director

6. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2019. For Stephen Wilson, Dan Hartley and Bill Christianson the nil-cost share options granted under Genus's Deferred Share Bonus Plan include an additional amount of 40%, 40% and 30% of salary respectively following achievement of Company milestones during the financial year ending 30 June 2019.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 2,832p

7,382

2. 2,832p

4,420

3. 2,832p

1,142

4. 2,832p

1,255

5. 2,832p

895

6. 2,832p

4,704

d.

Aggregated information

·; Aggregated volume

·; Price

 

 

 

n/a

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUUVORKBAKAAR
Date   Source Headline
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSINTERIM RESULTS
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.